Search: id:"swepub:oai:DiVA.org:uu-221428" >
Combinations of mut...
-
Adler, Marlen,1984-Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
(author)
Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli
- Article/chapterEnglish2016
Publisher, publication year, extent ...
-
2016-02-10
-
Oxford University Press (OUP),2016
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-221428
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-221428URI
-
https://doi.org/10.1093/jac/dkv475DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
The worldwide spread of ESBL-producing Enterobacteriaceae has led to an increased use of carbapenems, the group of beta-lactams with the broadest spectrum of activity. Bacterial resistance to carbapenems is mainly due to acquired carbapenemases or a combination of ESBL production and reduced drug influx via loss of outer-membrane porins. Here, we have studied the development of carbapenem resistance in Escherichia coli in the absence of beta-lactamases. We selected mutants with high-level carbapenem resistance through repeated serial passage in the presence of increasing concentrations of meropenem or ertapenem for similar to 60 generations. Isolated clones were whole-genome sequenced, and the order in which the identified mutations arose was determined in the passaged populations. Key mutations were reconstructed, and bacterial growth rates of populations and isolated clones and resistance levels to 23 antibiotics were measured. High-level resistance to carbapenems resulted from a combination of downstream effects of envZ mutation and target mutations in AcrAB-TolC-mediated drug export, together with PBP genes [mrdA (PBP2) after meropenem exposure or ftsI (PBP3) after ertapenem exposure]. Our results show that antibiotic resistance evolution can occur via several parallel pathways and that new mechanisms may appear after the most common pathways (i.e. beta-lactamases and loss of porins) have been eliminated. These findings suggest that strategies to target the most commonly observed resistance mechanisms might be hampered by the appearance of previously unknown parallel pathways to resistance.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Anjum, MehreenUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
(author)
-
Andersson, Dan I.Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)dan19789
(author)
-
Sandegren, LinusUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)lisan839
(author)
-
Uppsala universitetInstitutionen för medicinsk biokemi och mikrobiologi
(creator_code:org_t)
Related titles
-
In:Journal of Antimicrobial Chemotherapy: Oxford University Press (OUP)71:5, s. 1188-11980305-74531460-2091
Internet link
Find in a library
To the university's database